Skip to main content
Tags: azar | covid | vaccine | rollout | coronavirus

Azar Defends COVID Vaccine Rollout Process

alex azar speaks into microphone
United States Secretary of Health and Human Services Alex Azar (Tasos Katopodis/Getty Images)

By    |   Monday, 04 January 2021 12:36 PM EST

Health and Human Services Alex Azar on Monday insisted the rollout of the nation's coronavirus vaccines remain on track, after criticism last week that only 2 million people had been vaccinated by the end of the year, a number far below government goal of 20 million vaccinations. 

"We said our goal was to have 20 million first doses available in the month of December," Azar said on ABC's "Good Morning America." "Those are available, but there’s a lag between doses being available, them being ordered by the providers in the states, shipping, and then eventual vaccination, especially when you have Christmas and New Year’s in the middle.”

He also said he's surprised "there haven't been more glitches" in the "largest vaccination campaign in the history of the United States.”

According to the Centers for Disease Control and Prevention, 4.28 million vaccines had been given by Saturday, out of just over 13 million doses that have been distributed.  

Azar said the numbers are "on track" and that there has been a "rapid uptick" of vaccinations in the past 72 hours. 

There has also been some discussion about cutting doses of the vaccine to ensure more supply, including only giving a half dose or making sure everyone has one dose of the vaccine before being concerned about a second dose, but the available data does not support that, said Azar. 

"If different data is generated supporting different dosing schedules and the FDA approves it, that's what we'll do," said Azar. "We'll stick with the data we've got. In terms of doing the first dose without a second dose available, that's just not on the label. That's not what the data supports, knowing you won't have a second dose."

Meanwhile, the information could be available about the Johnson & Johnson vaccine, which will be a single-dose education, as well as others soon, said Azar. 

The growing COVID cases in the United States are pushing the need for the vaccine clinical trials, and "we could see data any time now" for candidates headed to the Food and Drug Administration for review, said Azar. 

Sandy Fitzgerald

Sandy Fitzgerald has more than three decades in journalism and serves as a general assignment writer for Newsmax covering news, media, and politics. 

© 2024 Newsmax. All rights reserved.


Politics
Health and Human Services Alex Azar on Monday insisted the rollout of the nation's coronavirus vaccines remain on track, after criticism last week that only 2 million people had been vaccinated by the end of the year...
azar, covid, vaccine, rollout, coronavirus
349
2021-36-04
Monday, 04 January 2021 12:36 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
Get the NewsmaxTV App for iOS Get the NewsmaxTV App for Android Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved